Literature DB >> 35729252

Sustained effects of single doses of classical psychedelics in humans.

Gitte M Knudsen1.   

Abstract

The serotonergic classical psychedelics include compounds that primarily activate the brain's serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca). The acute effects of these compounds are well-known as are their ability to increase the emotional state both in healthy people and in those with neuropsychiatric disorders. In particular psilocybin, the psychoactive constituent in "magic mushrooms", has shown great potential for treatment of anxiety and depression. A unique and compelling feature of psychedelics is that intake of just a single psychedelic dose is associated with long-lasting effects. This includes effects on personality, e.g., higher openness, and amelioration of depressive symptoms. This review focuses on these stunning effects and summarizes our current knowledge on which behavioral, biochemical, neuroimaging, and electrophysiological data support that the intriguing effects of psychedelics on the human brain and mind are based on neural plasticity. The review also points to so far understudied areas and suggests research questions to be addressed in future studies which potentially can help to understand the intriguing long-term effects after intake of a single (or a few) psychedelic doses.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 35729252     DOI: 10.1038/s41386-022-01361-x

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  44 in total

1.  Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.

Authors:  Katherine A MacLean; Matthew W Johnson; Roland R Griffiths
Journal:  J Psychopharmacol       Date:  2011-09-28       Impact factor: 4.153

2.  Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.

Authors:  Frederick S Barrett; Matthew W Johnson; Roland R Griffiths
Journal:  J Psychopharmacol       Date:  2015-10-06       Impact factor: 4.153

3.  LSD-induced entropic brain activity predicts subsequent personality change.

Authors:  A V Lebedev; M Kaelen; M Lövdén; J Nilsson; A Feilding; D J Nutt; R L Carhart-Harris
Journal:  Hum Brain Mapp       Date:  2016-05-06       Impact factor: 5.038

4.  LSD revisited. A ten-year follow-up of medical LSD use.

Authors:  W H McGlothlin; D O Arnold
Journal:  Arch Gen Psychiatry       Date:  1971-01

5.  Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety.

Authors:  Alan K Davis; Frederick S Barrett; Roland R Griffiths
Journal:  J Contextual Behav Sci       Date:  2019-11-16

6.  Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.

Authors:  Simon B Goldberg; Benjamin Shechet; Christopher R Nicholas; Chi Wing Ng; Geetanjali Deole; Zhuofan Chen; Charles L Raison
Journal:  Psychol Med       Date:  2020-11-04       Impact factor: 7.723

7.  Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.

Authors:  Roland R Griffiths; Matthew W Johnson; Michael A Carducci; Annie Umbricht; William A Richards; Brian D Richards; Mary P Cosimano; Margaret A Klinedinst
Journal:  J Psychopharmacol       Date:  2016-12       Impact factor: 4.153

8.  Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.

Authors:  Stephen Ross; Anthony Bossis; Jeffrey Guss; Gabrielle Agin-Liebes; Tara Malone; Barry Cohen; Sarah E Mennenga; Alexander Belser; Krystallia Kalliontzi; James Babb; Zhe Su; Patricia Corby; Brian L Schmidt
Journal:  J Psychopharmacol       Date:  2016-12       Impact factor: 4.153

9.  Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat.

Authors:  Lukasz Smigielski; Michael Kometer; Milan Scheidegger; Rainer Krähenmann; Theo Huber; Franz X Vollenweider
Journal:  Sci Rep       Date:  2019-10-24       Impact factor: 4.379

View more
  1 in total

Review 1.  The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference.

Authors:  Nina K Popova; Anton S Tsybko; Vladimir S Naumenko
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.